EBITDA for Callisto Pharmaceuticals Reaches Four Year High
Stock Quote:(N/A:CLSP)
09/02/2009
0.00
N/A
N/A
0
EBITDA for Callisto Pharmaceuticals Reaches Four Year High
Last
Price Change
% Chg
Volume
New York, NY, September 2, 2009-EbitdaEXTRA reports that negative EBITDA for Callisto Pharmaceuticals, Inc. (OTC:CLSP) for its twelve months ended June 30, 2009 was $(8,237,365), a 30% improvement ove ... read full story